tirzepatide fsa eligible Weight Loss Medications | GLP-1s FSA Eligibility for Compounded Semaglutide

At a Glance What It Is & Composition Semaglutide is a single-molecule GLP-1 receptor agonist an analogue of human GLP-1 engineered for a long half-life (about a week), which is what allows once-weekly rather than daily dosing

(2009a)

The Obesity Medicine Association does not recommend for, or against, compounding peptides

Individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, active pancreatitis, or severe kidney or liver disease should avoid this medication

Residents of Frankfort, Kentucky, have a reliable resource in Klinic for finding the right weight loss solution